AI-generated summary
The authors describe photobiomodulation, a form of low-level laser therapy using red and near-infrared light, and propose that it may have effects on the coronary arteries that could be promising for patients with chronic stable angina. The abstract frames this as a hypothesis or opportunity to explore rather than reporting measured results. No study data, sample size or outcome findings are presented in the abstract.
- Who or what was studied
- Patients with chronic stable angina, patients after acute myocardial infarction, and patients with ischemic heart conditions not accessible to current revascularization procedures (as proposed in the abstract)
- Wavelengths
- 600, 1000 nm
- Limits stated in the abstract
- The abstract reports no experimental data or results, so its proposed cardiac benefits remain untested as presented.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on link.springer.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 600-1000 nm
How to read a review: what to check before relying on this kind of research.
Terms in this paper: Nitric oxide, Low-level laser therapy, Near-infrared, Photobiomodulation, Laser. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.